Metabolism of 4′-modified analogs of doxorubicin. Unique glucuronidation pathway for 4′-epidoxorubicin
- 1 July 1984
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 20 (7), 919-926
- https://doi.org/10.1016/0277-5379(84)90165-2
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- 4′-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical dataCancer Treatment Reviews, 1983
- Pharmacokinetics of 4′-epi-doxorubicin in manInvestigational New Drugs, 1983
- In vitro and in vivo metabolism of VP 16–213 in the ratEuropean Journal of Cancer and Clinical Oncology, 1982
- Preliminary Clinical Experience with 4’-Epidoxorubicin in Advanced Human NeoplasiaPublished by Springer Nature ,1980
- Studies on the mode of interaction of 4'-epi-adriamycin and 4-demethoxy-daunomycin with DNABiochemical Pharmacology, 1978
- Model Systems for Cardiotoxic Effects of AnthracyclinesPublished by S. Karger AG ,1977
- Adriamycin: The Role of Lipid Peroxidation in Cardiac Toxicity and Tumor ResponseScience, 1977
- Reductive cleavage of anthracycline glycosides by microsomal nadphcytochrome c reductase.The Journal of Antibiotics, 1977
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- The preparation and properties of β-glucuronidase. 4. Inhibition by sugar acids and their lactonesBiochemical Journal, 1952